<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04490733</url>
  </required_header>
  <id_info>
    <org_study_id>201912231RINC</org_study_id>
    <nct_id>NCT04490733</nct_id>
  </id_info>
  <brief_title>Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer</brief_title>
  <official_title>Developing Risk Prediction Model of Mild Cognitive Impairment in Patients With Colorectal Cancer From Active Treatment to Survivor and Testing the Effect of Dual Task Walking on Improving Cognitive Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this three-year study are to explore cognitive function under different stages of&#xD;
      colorectal cancer (CRC) and its related factors; and understand its disturbance and coping&#xD;
      process caused by cancer-induced cognitive impairment (CICI) from patient perspective; and&#xD;
      further to test effect of dual-task walking on improving cognitive function in CRC patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Developing risk prediction model of mild cognitive impairment in patients with colorectal&#xD;
      cancer from active treatment to survivor by exploring the effect of surgery and chemotherapy&#xD;
      on CICI, and to identify high risk population; and testing the effect of dual-task walking on&#xD;
      improving cognitive function (memory, executive function and attention) in CRC patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 17, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-report Questionnaire</measure>
    <time_frame>Change from baseline cognitive function at 12 months</time_frame>
    <description>The questionnaire includes 37 items to assess perceived cognitive function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological battery test</measure>
    <time_frame>Change from baseline cognitive function at 12 months</time_frame>
    <description>Three neuropsychological battery tests will be used to assess cognitive function of executive function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological battery test</measure>
    <time_frame>Change from baseline cognitive function at 12 months</time_frame>
    <description>One neuropsychological battery test will be used to assess cognitive function of attention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological battery test</measure>
    <time_frame>Change from baseline cognitive function at 12 months</time_frame>
    <description>Five neuropsychological battery tests will be used to assess cognitive function of memory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-report Questionnaire</measure>
    <time_frame>Change from baseline symptom at 12 months</time_frame>
    <description>The questionnaire includes 24 items to assess symptom severity</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Self-report Questionnaire</measure>
    <time_frame>Change from baseline fatigue at 12 months</time_frame>
    <description>The questionnaire includes 15 items to assess fatigue level</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-report Questionnaire</measure>
    <time_frame>Change from baseline depression symptom at 12 months</time_frame>
    <description>The questionnaire includes 20 items to assess frequency of depression symptom</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">355</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the experimental group will receive 3 times interventions during 10th to 12th course of chemotherapy and 12 weekly phone-call to assess effect and barriers of dual-task walking.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in control group will receive usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>dual-task walking</intervention_name>
    <description>Participants will receive 3 times interventions during 10th to 12th course of chemotherapy and 12 weekly phone-call to assess effect and barriers of dual-task walking.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with newly diagnosed stage I to III colorectal cancer and Montreal Cognitive&#xD;
             Assessment (MoCA) &lt; 24.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with cancer other than colorectal cancer or have cancer recurrence.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiow-Ching Shun, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shiow-Ching Shun, PHD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>88439</phone_ext>
    <email>scshun@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiow-Ching Shun, PHD</last_name>
      <phone>886-2-2312-3456</phone>
      <phone_ext>88439</phone_ext>
      <email>scshun@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>cognitive impairment</keyword>
  <keyword>chemotherapy</keyword>
  <keyword>dual-task walking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

